+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Genentech, Inc.  - logo

Genentech, Inc., a biotechnology company, engages in the research, development, manufacture, and marketing of biotechnology products for treating patients with serious or life-threatening diseases in the United States. It offers molecular entities and medicines in the areas of oncology, immunology, neuroscience, metabolism, and infectious diseases. The company was founded in 1976 and is headquartered in South San Francisco, California. Genentech operates as a subsidiary of Roche Holdings, Inc.

Angiosarcoma Treatment Market - Global Strategic Business Report - Product Thumbnail Image

Angiosarcoma Treatment Market - Global Strategic Business Report

  • Report
  • December 2025
  • 390 Pages
  • Global
From
From
From
From
From
From
Therapeutic Proteins Market Report 2025 - Product Thumbnail Image

Therapeutic Proteins Market Report 2025

  • Report
  • April 2025
  • 175 Pages
  • Global
From
Cancer biologics Market Report 2025 - Product Thumbnail Image

Cancer biologics Market Report 2025

  • Report
  • April 2025
  • 250 Pages
  • Global
From
Primary Sclerosing Cholangitis - Pipeline Insight, 2025 - Product Thumbnail Image

Primary Sclerosing Cholangitis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 50 Pages
  • Global
From
From
From
Next-Generation Antibody Therapeutics Market Report 2025 - Product Thumbnail Image

Next-Generation Antibody Therapeutics Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
From
Acute Ischemic Stroke Drugs Market Report 2025 - Product Thumbnail Image

Acute Ischemic Stroke Drugs Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
Loading Indicator